Denmark
Orbis Medicines, founded in 2021, is at the forefront of transforming drug discovery. With the slogan "Reshaping the future of drug discovery," the company is dedicated to developing a comprehensive platform designed to discover, develop, and deliver drug candidates targeting challenging medical conditions.
Headquartered in Denmark, Orbis Medicines successfully closed a €26.00M Seed Round investment on 29 February 2024. This financial backing from notable investors, Novo Holdings and Forbion, underscores strong confidence in the company’s innovative approach and its potential to influence the pharmaceutical industry significantly.
The company's cutting-edge technology, supported by influential industry players, positions it as a compelling prospect for investors looking to engage in the rapidly advancing biopharmaceutical field. As Orbis Medicines continues its journey, it promises to be a significant contributor to future breakthroughs in drug discovery.
-logo.jpg "New England Discovery Partners (NEDP)"){kind=logo}
deepmirror